Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Geely Automobile Holdings on Wednesday maintained its annual sales target as it bet on new product launches. However, the company warned that its near-term performance would be affected by a global chip shortage and resurgent COVID-19 infections.

Geely reported a 22% year-on-year surge to 45 billion yuan ($6.94 billion) in its six-month revenue to June 30th, supported by a diversified product mix.

The company’s total vehicle sales increased 19% year-on-year to 630,237 units during the period, but underperformed a 27% growth in the Chinese overall passenger vehicle sales.

On the other hand, Geely’s six-month net profit rose a modest 4% year-on-year to 2.38 billion yuan as a result of share-based payments of 641 million yuan.

“We believe the rise in raw material prices should subside in the remainder of the year but the chip shortage could persist during the period,” Geely said in a statement.

“Despite these, the upcoming launch of more new and competitive vehicle models should enable the Group to perform better in the second half,” it added.

Additionally, Geely maintained its full-year sales objective of 1.53 million vehicles.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Forex Market: GBP/CAD daily forecastForex Market: GBP/CAD daily forecast During yesterday’s trading session GBP/CAD traded within the range of 1.8466-1.8570 and closed at 1.8488.At 6:18 GMT today GBP/CAD was losing 0.05% for the day to trade at 1.8482. The pair touched a daily low at 1.8469 at 6:05 […]
  • UBS Sees Limited Upside for Pfizer Despite Obesity Pipeline PushUBS Sees Limited Upside for Pfizer Despite Obesity Pipeline Push Key Moments UBS began coverage of Pfizer with a Neutral rating and a $25 price target, citing continued revenue uncertainty. Meanwhile, analysts estimate that $15–20 billion of Pfizer’s annual revenue could be at risk from […]
  • EUR/USD trades little changed after EZ current account dataEUR/USD trades little changed after EZ current account data The euro traded slightly changed and in proximity to over one-week highs against the US dollar on Monday, after Euro zones current account produced a lesser than projected surplus in September, while markets awaited the release of the minutes […]
  • EUR/GBP Down 0.54% to 0.8558, UK Wage Growth at Nearly 6%EUR/GBP Down 0.54% to 0.8558, UK Wage Growth at Nearly 6% Key momentsThe EUR/GBP fell 0.54% to 0.8558 on Tuesday. Figures released by the ONS provided fresh insights into the state of employment within the UK economy, with vacancy reducing to a notable extent while wages saw an […]
  • Forex Market: EUR/GBP daily forecastForex Market: EUR/GBP daily forecast During yesterday’s trading session EUR/GBP traded within the range of 0.8120-0.8157 and closed at 0.8139.At 6:32 GMT today EUR/GBP was losing 0.01% for the day to trade at 0.8135. The pair touched a daily low at 0.8135 at 6:31 […]
  • Barrick Gold announces $1 billion share repurchase program as fourth-quarter results beatBarrick Gold announces $1 billion share repurchase program as fourth-quarter results beat Barrick Gold Corp announced yesterday a share repurchase program of up to $1 billion and raised dividend payout, as it reported better-than-expected fourth-quarter results.Total revenue went up 17% from the prior quarter to $3.310 […]